| 000 | 01779 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518001036.0 | ||
| 264 | 0 | _c20190614 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1460-2083 | ||
| 024 | 7 |
_a10.1093/hmg/ddy343 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWaskowicz, Lauren R | |
| 245 | 0 | 0 |
_aBezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia. _h[electronic resource] |
| 260 |
_bHuman molecular genetics _c01 2019 |
||
| 300 |
_a143-154 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAutophagy _xdrug effects |
| 650 | 0 | 4 |
_aBezafibrate _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 |
_aGlucose-6-Phosphatase _xmetabolism |
| 650 | 0 | 4 |
_aGlucose-6-Phosphate _xmetabolism |
| 650 | 0 | 4 |
_aGlycogen _xmetabolism |
| 650 | 0 | 4 |
_aGlycogen Storage Disease Type I _xdrug therapy |
| 650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aTriglycerides _xmetabolism |
| 700 | 1 | _aZhou, Jin | |
| 700 | 1 | _aLandau, Dustin J | |
| 700 | 1 | _aBrooks, Elizabeth D | |
| 700 | 1 | _aLim, Andrea | |
| 700 | 1 | _aYavarow, Zollie A | |
| 700 | 1 | _aKudo, Tsubasa | |
| 700 | 1 | _aZhang, Haoyue | |
| 700 | 1 | _aWu, Yajun | |
| 700 | 1 | _aGrant, Stuart | |
| 700 | 1 | _aYoung, Sarah P | |
| 700 | 1 | _aHuat, Bay Boon | |
| 700 | 1 | _aYen, Paul M | |
| 700 | 1 | _aKoeberl, Dwight D | |
| 773 | 0 |
_tHuman molecular genetics _gvol. 28 _gno. 1 _gp. 143-154 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/hmg/ddy343 _zAvailable from publisher's website |
| 999 |
_c28876121 _d28876121 |
||